Ignite Creation Date:
2025-12-25 @ 12:54 AM
Ignite Modification Date:
2026-04-22 @ 7:02 PM
Study NCT ID:
NCT05567367
Status:
COMPLETED
Last Update Posted:
2025-09-22
First Post:
2022-04-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Healthy Volunteer Study Evaluating the the Safety, Tolerability, and Pharmacokinetics of RT234
Sponsor:
Respira Therapeutics, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Healthy Volunteer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Pulmonary Arterial Hypertension | View |
| None | Familial Primary Pulmonary Hypertension | View |
| None | Vascular Diseases | View |
| None | Cardiovascular Diseases | View |
| None | Hypertension, Pulmonary | View |
| None | Lung Diseases | View |
| None | Respiratory Tract Diseases | View |
| None | Vardenafil Dihydrochloride | View |
| None | Inhaled Vardenafil | View |
| None | Vasodilator Agents | View |
| None | Phosphodiesterase 5 Inhibitors | View |
| None | Phosphodiesterase Inhibitors | View |
| None | Enzyme Inhibitors | View |
| None | Molecular Mechanisms of Pharmacological Action | View |